David Baker, a Nobel Prize-winning scientist renowned for his pioneering work in protein engineering, shares exciting insights on AI's role in drug discovery. He discusses the evolution of RosettaFold and how AI-driven tools can design proteins to neutralize pathogens and combat neurodegenerative diseases. The conversation delves into the implications for healthcare and highlights the integration of synthetic biology with AI. With a focus on advancing therapeutic options, Baker envisions a future where engineered proteins drastically reshape medicine.